Compared with participants without NAFLD, participants with NAFLD showed significantly decreased levels of SI (P < 0.001) and TSAT (P < 0.001) and a significantly increased level of sTfR (P < 0.001) (Table 1). This evidence concerns the gene TFRC and metabolic dysfunction-associated steatotic liver disease.